Trials / Not Yet Recruiting
Not Yet RecruitingNCT06706726
To Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer
A Prospective, Single-center, Double-arm Clinical Study to Evaluate the Effectiveness and Safety of Single-port Robotic-assisted Subcutaneous Gland Resection Combined With Immediate Breast Reconstruction in Breast Cancer
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The new technology of robotic surgery system, as an emerging technology, has shown certain application prospects in breast surgery. However, the new technology of robotic surgery system in China in the treatment of breast cancer is still in the exploratory stage and needs to be further improved. This prospective, single-center, double-arm clinical study was conducted to use the single-port robot and evaluate the effectiveness and safety of the subcutaneous gland resection combined with immediate breast reconstruction in breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | sentinel lymph node biopsy | sentinel lymph node biopsy during the management of breast cancer |
| PROCEDURE | Single-port robotic-assisted axillary lymph node dissection | Single-port robotic-assisted(Endoscopic Instrument Control System SP1000) axillary lymph node dissection during the management of breast cancer |
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
- First posted
- 2024-11-27
- Last updated
- 2024-11-29
Source: ClinicalTrials.gov record NCT06706726. Inclusion in this directory is not an endorsement.